Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-1459
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study ; day:31 ; month:8 ; year:2020 ; pages:1-10
Journal of neurology ; (31.8.2020), 1-10

Creator
Nicoletti, Alessandra
Luca, Antonina
Baschi, Roberta
Cicero, Calogero Edoardo
Mostile, Giovanni
Davì, Marco
Bianca, Giuseppe La
Restivo, Vincenzo
Zappia, Mario
Monastero, Roberto
Contributor
SpringerLink (Online service)

DOI
10.1007/s00415-020-10189-8
URN
urn:nbn:de:101:1-2020101819110645023196
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Nicoletti, Alessandra
  • Luca, Antonina
  • Baschi, Roberta
  • Cicero, Calogero Edoardo
  • Mostile, Giovanni
  • Davì, Marco
  • Bianca, Giuseppe La
  • Restivo, Vincenzo
  • Zappia, Mario
  • Monastero, Roberto
  • SpringerLink (Online service)

Other Objects (12)

Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort

Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort

Impairment of endothelial function in Parkinson’s disease

Impairment of endothelial function in Parkinson’s disease

The correlation between enlarged perivascular spaces and cognitive impairment in Parkinson’s disease and vascular parkinsonism

The correlation between enlarged perivascular spaces and cognitive impairment in Parkinson’s disease and vascular parkinsonism

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

Advanced brain aging in Parkinson’s disease with cognitive impairment

Advanced brain aging in Parkinson’s disease with cognitive impairment

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study

Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study

Emotion-Specific Affective Theory of Mind Impairment in Parkinson’s Disease

Emotion-Specific Affective Theory of Mind Impairment in Parkinson’s Disease

Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?

Theory of mind in mild cognitive impairment and Parkinson’s disease: The role of memory impairment

Theory of mind in mild cognitive impairment and Parkinson’s disease: The role of memory impairment

NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease

NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease

Related objects